Qingpeng Zhang | sciencenewsnet.in

Breaking News

Interplay between mesenchymal stem cells and macrophages: Promoting bone tissue repair

Biological scaffold as potential platforms for stem cells: Current development and applications in wound healing

Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19

Effects of high glucose and severe hypoxia on the biological behavior of mesenchymal stem cells at various passages

Gossypol acetic acid regulates leukemia stem cells by degrading LRPPRC via inhibiting IL-6/JAK1/STAT3 signaling or resulting mitochondrial dysfunction

Expansion of human umbilical cord derived mesenchymal stem cells in regenerative medicine

Unveiling the role of hypoxia-inducible factor 2alpha in osteoporosis: Implications for bone health

Reveal more mechanisms of precondition mesenchymal stem cells inhibiting inflammation

Adipose-derived regenerative therapies for the treatment of knee osteoarthritis

Barcodes expand range of high-resolution sensor

26 Apr, 2024

Preparing for Coming RSV, Influenza Epidemics

January 17, 2023 sarah JonasResearch Results

Nonpharmaceutical interventions slowed the spread of COVID-19 and other infectious diseases but now, as NPIs are lifted, countries are seeing a resurgence in several respiratory diseases. In Chaos, scientists, using data from Hong Kong to develop their model, describe a threshold control method that can be used to predict the best time to lift NPIs without overwhelming the hospital systems when these other respiratory diseases inevitably surge back. They found that reintroducing NPI measures when a threshold of 600 severe cases is reached could ensure that the hospital system in Hong Kong is not overwhelmed by severely infected patients.